warfarin sodium 1 MG Oral Tablet [Jantoven]
warfarin sodium
RxCUI: 855292
What the CMS Formulary Data Shows for warfarin sodium 1 MG Oral Tablet [Jantoven]
Per the CMS 2026 Part D formulary file, warfarin sodium 1 MG Oral Tablet [Jantoven] (RxNorm concept RXCUI 855292, generic name warfarin sodium) appears on 324 distinct formulary files spanning 4,939 Medicare Part D plan offerings - 97.5% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 3, with a cross-plan average of Tier 1.
Real-world access to warfarin sodium 1 MG Oral Tablet [Jantoven] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 942,245 Part D beneficiaries filled warfarin sodium 1 MG Oral Tablet [Jantoven] in 2023, with total plan-and-beneficiary spending of $70,883,350 and an average per-beneficiary annual cost of $75.23. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry warfarin sodium 1 MG Oral Tablet [Jantoven] today.
Coverage Details
- Formularies covering
- 324
- Plans covering
- 4,939
- Coverage rate
- 97.5%
- Tier range
- Tier 1 – Tier 3
- Average tier
- Tier 1, Preferred Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 942,245
- Total spending
- $70,883,350
- Avg per beneficiary
- $75.23
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering warfarin sodium 1 MG Oral Tablet [Jantoven]
2 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| AARP Medicare Rx Preferred from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T1 | No | No | $0 | - |
| AARP Medicare Rx Preferred from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T1 | No | No | $0 | - |
Medicare Advantage Plans (MA-PD) Covering warfarin sodium 1 MG Oral Tablet [Jantoven]
98 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is warfarin sodium 1 MG Oral Tablet [Jantoven] covered by Medicare Part D?
Yes, warfarin sodium 1 MG Oral Tablet [Jantoven] is covered by 4,939 Medicare Part D plans (97.5% of all Part D formularies).
What tier is warfarin sodium 1 MG Oral Tablet [Jantoven] on Medicare Part D plans?
warfarin sodium 1 MG Oral Tablet [Jantoven] averages Tier 1 across Part D plans, ranging from Tier 1 to Tier 3.
Does warfarin sodium 1 MG Oral Tablet [Jantoven] require prior authorization?
0% of Part D formularies require prior authorization for warfarin sodium 1 MG Oral Tablet [Jantoven]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on warfarin sodium 1 MG Oral Tablet [Jantoven]?
In 2023, total Medicare Part D spending on warfarin sodium 1 MG Oral Tablet [Jantoven] was $70,883,350, covering 942,245 beneficiaries. The average spend per beneficiary was $75.23.
Read our methodology - how this data is sourced, computed, and verified.